Thermo Fisher Scientific has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing business for $877 million in cash. Novasep's viral vector manufacturing business provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results